The buzz around the potential of Precision Medicine continues as new technologies, more powerful computing and our ability to store, share and interpret Big Data increases. On this podcast Steve Coldicott and Scott Buckler chat about all aspects of the industry with patients, healthcare industry and research professionals about creating personalised medicines for each and every one of us.
Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption. During this episode, Dr Anthony Khawaja chats with Scott Buckler about the need for precision management in glaucoma.
For more content, and to see many episodes of this podcast in video form, please visit our website: https://precisionmedicineforum.com/